Sermorelin safety evidence
What are the side effects of sermorelin?
Reported sermorelin side effects in historical drug information include injection-site pain, redness or swelling, with less common symptoms such as headache, dizziness, flushing and sleepiness. That list does not predict what one person will experience. The current online products compared by Longevity Ranked are compounded, so individual suitability and product quality are separate questions. Small, short human studies cannot establish long-term safety for every adult, and a provider's marketing page is not an adverse-event database.
Separates historical finished-product side effects, small-study observations and present-day compounded-product quality instead of collapsing them into one generic warning list. It is a bounded source review, not a systematic review or individual medical advice.
Commonly listed
Injection-site pain, redness or swelling
Evidence limit
Small and short human studies
Current market
Online products are compounded and not FDA-approved
What side effects have been reported with sermorelin?
Historical clinical information lists injection-site pain, redness and swelling among the more common reactions. It also lists less common or rare symptoms including itching, trouble swallowing, dizziness, flushing, headache, sleepiness and restlessness.
A symptom list is not a frequency estimate for a current compounded product. Product composition, administration, a person's medical history and reporting methods can differ from the historical reference.
What did human sermorelin studies report about safety?
An early study of GRF(1-29) in five healthy volunteers reported no serious side effects while measuring hormone responses. Another six-week study enrolled only eleven older men and focused on hormone, strength and body-composition outcomes.
Those studies help establish a mechanism and selected short-term observations. They are too small and short to settle uncommon reactions, long-term safety or suitability for the broader population now seeing online wellness offers.
Do compounded sermorelin products add different risks?
Yes. FDA does not review compounded drugs before marketing for safety, effectiveness or quality. Contamination, incorrect strength and other quality failures can create risks that are separate from the active ingredient's expected effects.
FDA recall and warning records have included specific compounded sermorelin products or lots. Those actions do not show that every current provider has the same problem, but they make the dispensing pharmacy, lot information and quality process reasonable questions before treatment.
When should a reader seek medical help?
A page cannot triage an individual reaction. New trouble breathing or swallowing, faintness, severe symptoms or a rapidly worsening reaction needs prompt clinical assessment. For non-urgent symptoms, contact the prescribing clinician and use the actual product label and pharmacy information.
Do not change a prescription or self-treat a suspected reaction based on this article. The responsible clinician needs the timing, symptoms, other medicines and exact compounded product.
Where can I compare current sermorelin providers?
The pages below compare public product and contract information. Some are labeled partner links. Any commission we receive does not change evidence claims or table order.
Partner link; we may earn a commission. Editorial order and findings do not change.
Compounded; not FDA-approved. Prescription required only if a licensed provider finds it appropriate.
Which sources support this answer?
Sources were checked September 21, 2026. They define the product, population and evidence limits used above; they do not determine individual suitability.
- Mayo Clinic: historical sermorelin injection description and side effects
- PubMed: GRF(1-29) study in five healthy volunteers
- PubMed: six-week GHRH study in eleven older men
- FDA: understanding the risks of compounded drugs
- FDA: Olympia Pharmacy compounded-product recall
- FDA: Town and Country warning letter and sermorelin lot recall
These are products marketed in the longevity category, not established lifespan-extension treatments. Compounded drugs are not FDA-approved. This publication compares public information; a clinician must assess individual suitability. How we compare.